Table 2 Findings, treatment, and prognosis associated with isolated intracranial hypertension in patients with NBD
Article | Lumbar CSF pressure (mmH2O) | Routine and biochemical tests of CSF | Brain imaging | Inflammatory markers | Treatment | Prognosis |
|---|---|---|---|---|---|---|
Teh LS, et al. [7]/1990 | >300 | - | - | N | GCS, Aza | Remission in 1 month, recurrence after 6 months, and final recovery |
>300 | - | - | N | GCS, Aza | Remission after 1 week, posterior optic atrophy | |
Pamir, et al. [8]/1981 | 300 | Pro 20 mg/dl | N | ESR 81 | GCS, Ac | Recovery after 4 months |
300 | Pro 30 mg/dl | - | ESR 50 | GCS, Ac, Bitemporal decompression. | Secondary optic atrophy after 1 year | |
260 | 108 mg/dl | Encephaledema | N | GCS, Ac | Remission after 2 months | |
Wilkins, et al. [9]/1986 | Raised | - | - | ESR 33 | Chlorambucil | Remission |
320 | - | - | N | GCS, Chlorambucil | Remission, relapse after 8 months, and recovery | |
Lin, et al. [10]/2021 | 354 | - | - | N | GCS, Ac, Aza | Remission after 6 months |
Neudorf, et al. [11]/2003 | 500 | - | - | N | GCS, Ac→Colchicine | Recovery |
Akdal, et al. [10]/2017 | >250 | 2 cases WBC >5 | - | N | GCS, Ac, Aza; 1 case of optic nerve sheath fenestration | 1 case of progression of irregular medication to parenchyma injury, remission in others |
Current report | 460 | - | - | - | GCS, Az, Dehydrator | 8-day remission |